You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 7 No. 1, Jan-Feb 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Facial Plastic Surgery
 •Biomaterials and Implants
 •Alert me on articles by topic

Quantitative Study of Tissue-Engineered Cartilage With Human Bone Marrow Mesenchymal Stem Cells

Yonggang Pang, MD; Pengcheng Cui, MD; Wenxian Chen, MD; Pengfei Gao, MD; Huizhong Zhang, MD

Arch Facial Plast Surg. 2005;7:7-11.

Objectives  To assess the possibility of cartilage tissue engineering using human mesenchymal stem cells (hMSCs) and to investigate the quantitative relationship between hMSCs and engineered cartilage.

Design  Human mesenchymal stem cells were cultured, cryopreserved, and expanded in vitro. Surface antigens were detected by flow cytometry. In vitro chondrogenesis of hMSCs and cryopreserved hMSCs was performed. The chondrogenesis-induced hMSCs were seeded onto polyglycolic acid scaffolds, cultured in vitro for 3 weeks in chondrogenic medium, and then implanted into nude mice. The implants were harvested after 10 weeks and examined with histologic and immunochemical staining.

Results  The construction of cartilages was identified grossly and histologically: 1.9 to 2.5 x 107 nucleated cells were obtained from 1 mL of bone marrow, and about 1 to x 106 hMSCs were obtained from the primary culture. The number of hMSCs tripled at every passage and reached 1.4 to 2.8 x 1012 at passage 15. The purity of hMSCs was 95% and 98% at the primary and the fourth passages, respectively. Twenty-one days was the optimal (induction rate, 95%) induction time, with no apparent differences in induction rates among different passages. Based on our findings, hMSCs from 0.07 to 0.14 mL of bone marrow, expanded during 4 passages and induced for 21 days, would be sufficient to engineer 1 cm2 of cartilage, 3-mm thick.

Conclusion  Quantitative standards of hMSCs as seed cells for cartilage tissue engineering were established and may have value for later clinical work.


Author Affiliations: Department of Otorhinolaryngology (Drs Pang, Cui, Chen, and Gao) and Central Laboratory (Dr Zhang), TangDu Hospital, The Fourth Military Medical University, Xi’an, People’s Republic of China.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Differentiation Potential of Multipotent Progenitor Cells Derived from War-Traumatized Muscle Tissue
Nesti et al.
JBJS 2008;90:2390-2398.
ABSTRACT | FULL TEXT  

Immune response to stem cells and strategies to induce tolerance
Batten et al.
Phil Trans R Soc B 2007;362:1343-1356.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.